Insider Selling: Afya (NASDAQ:AFYA) VP Sells $623,115.00 in Stock

Afya Limited (NASDAQ:AFYAGet Free Report) VP Lelio De Souza Junior sold 41,541 shares of the stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of $15.00, for a total value of $623,115.00. Following the transaction, the vice president directly owned 36,204 shares of the company’s stock, valued at approximately $543,060. This trade represents a 53.43% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Lelio De Souza Junior also recently made the following trade(s):

  • On Thursday, April 9th, Lelio De Souza Junior sold 16,279 shares of Afya stock. The shares were sold at an average price of $14.53, for a total value of $236,533.87.
  • On Tuesday, April 7th, Lelio De Souza Junior sold 26,753 shares of Afya stock. The shares were sold at an average price of $14.95, for a total value of $399,957.35.

Afya Stock Up 1.8%

Afya stock opened at $15.27 on Friday. The stock’s 50 day moving average price is $14.28 and its 200 day moving average price is $14.54. Afya Limited has a 1-year low of $13.00 and a 1-year high of $17.68. The company has a market cap of $1.43 billion, a PE ratio of 9.98, a price-to-earnings-growth ratio of 1.54 and a beta of 0.32. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.78 and a quick ratio of 1.78.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on AFYA. Bank of America reaffirmed a “neutral” rating on shares of Afya in a research note on Thursday, June 11th. Weiss Ratings reissued a “hold (c)” rating on shares of Afya in a report on Monday, April 20th. Wall Street Zen lowered shares of Afya from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 2nd. Zacks Research cut shares of Afya from a “strong-buy” rating to a “hold” rating in a report on Wednesday, May 6th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Afya from $21.50 to $21.00 and set a “neutral” rating for the company in a report on Monday, June 22nd. One investment analyst has rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $17.10.

Read Our Latest Analysis on Afya

Institutional Trading of Afya

Several large investors have recently bought and sold shares of AFYA. Van ECK Associates Corp raised its position in shares of Afya by 15.7% in the third quarter. Van ECK Associates Corp now owns 10,170 shares of the company’s stock valued at $159,000 after buying an additional 1,377 shares during the last quarter. Daiwa Securities Group Inc. acquired a new stake in Afya during the fourth quarter worth approximately $43,000. Arrowstreet Capital Limited Partnership grew its stake in Afya by 5.6% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 68,169 shares of the company’s stock worth $1,217,000 after acquiring an additional 3,626 shares during the period. Militia Capital Partners LP purchased a new stake in Afya in the 2nd quarter worth approximately $71,000. Finally, Fairtree Asset Management Pty Ltd raised its holdings in Afya by 22.3% in the 4th quarter. Fairtree Asset Management Pty Ltd now owns 30,697 shares of the company’s stock valued at $473,000 after acquiring an additional 5,599 shares during the last quarter. Institutional investors and hedge funds own 88.02% of the company’s stock.

About Afya

(Get Free Report)

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.

See Also

Insider Buying and Selling by Quarter for Afya (NASDAQ:AFYA)

Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.